Medicare’s Local and National Coverage Determinations GuideMedical coverage under Medicaid is determined by the Centers for Medicaid and Medicare Services through the regulatory process and outlined in documents known as local coverage determinations (LCDS) and national coverage determinations (NCDS). Most urological services are covered under local coverage determinations, decisions made by a Medicare Administrative Contractor (MAC) on covering a particular item or service in a MAC's jurisdiction (region). We have collected links to many of the LCDs affecting urological services below; this piece will be updated to keep the links up to date with the latest versions of the coverage determinations. For current coverage on new and modified Medicare coverage determinations, you can view Medicare’s What’s New Report at the following links:
Local Coverage Determinations Biomarkers for Oncology MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers Genetic Testing in Oncology: Specific Tests Prostate Cancer Detection with IsoPSA Transurethral Waterjet Ablation of the Prostate Urodynamics Prostate Cancer Screening Tests Urine Culture, Bacterial Tumor Antigen by Immunoassay - CA 125 |
Announcements
Introducing LUGPALearn: Explore. Learn. Earn CME.
Learn how to have your facility become a SRC/NAFC Center of Excellence In Continence Care for Women.
LUGPA groups will receive a discount on certification fees.
LUGPA members can login to access past content On Demand.